Pharmacokinetic dosing of aminoglycosides: a controlled trial.
about
Computerized advice on drug dosage to improve prescribing practiceAcute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatricsTherapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveInhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analoguesAntimicrobial Stewardship: How the Microbiology Laboratory Can Right the ShipAerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.Revisiting the loading dose of amikacin for patients with severe sepsis and septic shockOutcomes in patients with gram-negative sepsis treated with gentamicinHow do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Management of infectious complications in the hematopoietic stem cell transplant recipient.Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.Usage Pattern and Serum Level Measurement of Amikacin in the Internal Medicine Ward of the Largest Referral Hospital in the South of Iran: A Pharmacoepidemiological Study.Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaPharmacological rationale for antibiotic treatment of intra-abdominal infections.Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acidThe strategy of antibiotic use in critically ill neutropenic patientsRational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Approaches for dosage individualisation in critically ill patients.Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature.Therapeutic drug monitoring of anti-infective agents in critically ill patients.Estimating drug-free period using a graphical method: an alternative way to monitor extended-interval dosing of gentamicin therapy.Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisAugmenting effect of antibiotics on endotoxin activity may cause a safety problem.Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles.Adsorption of amikacin, a significant mechanism of elimination by hemofiltrationOnce versus individualized multiple daily dosing of aminoglycosides in critically ill patientsGentamicin-associated acute kidney injury.Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers.Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
P2860
Q24202497-BB2D4AE2-9FCC-437A-B97F-B6BBF8348EF8Q26745670-5188E973-EA61-40EE-A190-844DDA9EB99EQ26853629-0E320A17-C5FC-455E-9519-51E909ABA8DAQ27009221-590AA092-4663-4AE2-B783-FAEC1014A6BFQ27673672-2A7D60EE-FD99-4ABE-AAEA-04D1C311A1D1Q28068503-07F740CF-65B1-4EC3-9575-A6C1EC59CB48Q30830192-FBB6E620-C847-4AA7-AEC3-658BE86BDB26Q33919190-C70039DB-98AB-4463-9B18-6970B222F16BQ33949330-8D357176-E3E8-4ADF-8AA5-623852A2B737Q34894900-D9CE3030-DB8E-411C-B689-7C44598A69D9Q35675979-7D1D6371-AB3A-4D58-969B-A2379FF59269Q36366980-16F65FE0-C40F-4D80-8799-E88BBC3373F8Q36925002-5C801E02-5B6D-4D83-BBE9-77D11296FDF4Q36975688-E153D83D-76C2-43E7-857D-139007E3A4D5Q37050322-EE6CADED-54FA-4BD6-B224-D5047C3A28BCQ37220711-874605D1-F99B-486F-9695-82FDBB58485CQ37557851-556163C8-DC36-4766-A920-FD07FEE4FC06Q37701873-13DAE87A-48D7-4BB3-ACD9-CD0900A34D26Q37929895-5F67D3D2-E216-42F1-A26A-4444A959A8CBQ38070006-591495C6-9A60-4143-9DC9-F010FCD8A6B1Q38090988-0814A85A-5C5C-4F8B-9BBD-56FDCC7040EAQ38125209-6E6A2046-430E-4205-BF6D-498070997F6FQ38239999-C3A98713-5595-41BB-A677-F87F21A1B7CFQ38790740-FAE21B6B-9634-4C2A-9270-A4B4D77EB288Q39015529-9BD96FA1-302C-4297-8880-7AFA03E5CCCCQ39030684-7DE3FAF2-A178-44A9-80EA-B0421E87C048Q40586961-4E516BDA-ACCA-44A4-A60F-7E611B98D522Q41948736-12D20846-401E-4B6A-90B6-C1759465925FQ42133019-B9F4F6C6-E806-4550-A116-9D349111BC86Q42556968-C30D55F7-F5B7-4FBA-94D9-081CD3BE3052Q43263735-F05C3C41-96BB-4CB6-B88C-576EB68F298DQ45978260-A6232E56-55EA-41A9-BDA6-27CA6597A3C4Q46728031-730C180A-245D-483B-9263-863DFC5BC882Q47332682-58B424C4-1690-4F99-9938-63AAEE2D7122Q51092520-7FCBF8C2-40E4-491D-9F31-EE347A71106AQ51423932-2579B75C-8F97-4832-88DF-549680B03EA2Q51813710-68E667D3-0AF5-4E17-B153-3A99BB38A4FC
P2860
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@en
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@nl
type
label
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@en
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@nl
prefLabel
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@en
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@nl
P2093
P1476
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
@en
P2093
Abraham Danon
Aviel Sidi
Carmi Bartal
Francisc Schlaeffer
Klaris Reisenberg
Michael Alkan
Rosa Smoliakov
Yaniv Almog
P304
P356
10.1016/S0002-9343(02)01476-6
P407
P577
2003-02-01T00:00:00Z